Ignacio Durán

Great Ormond Street Hospital — United Kingdom

Medicine · Health Sciences

53h-index16.6kcitations345works23.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(108), Cancer Immunotherapy and Biomarkers(74), Urinary and Genital Oncology Studies(69), Renal cell carcinoma treatment(61), Prostate Cancer Treatment and Research(43)

Publications342 total

Abstracts of the 2025 International Kidney Cancer Symposium (IKCS) Europe
2025Open Access
A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract
Future Oncology·2025
Olgularla Kadın Hastalıkları ve Doğum II
2025Open Access
Shaping AI-Based Decision Support in Kidney Cancer: Multidisciplinary Consensus from the IKCSEU25 ART Think Tank
2025Open Access
Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trial
Annals of Oncology·2025Open Access
Feasibility of Wave Health to monitor electronic patient-reported outcomes (ePROs) in prostate cancer patients
ESMO Real World Data and Digital Oncology·2025Open Access
1058P Transcriptomic insights into cisplatin resistance in testicular germ cell tumors: Molecular pathways and tumor microenvironment
Annals of Oncology·2025
International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) classification and regression tree analysis to characterize objective response rates (ORR) in metastatic renal cell carcinoma (mRCC).
Journal of Clinical Oncology·2025
Exploratory analysis of responders from the phase 3 EV-302 trial of enfortumab vedotin plus pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).
Journal of Clinical Oncology·2025· 4 cited
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Clinical Genitourinary Cancer·2025· 2 cited
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial
Annals of Oncology·2025· 51 cited
Spatial biomarkers of response to neoadjuvant therapy in muscle-invasive bladder cancer: the DUTRENEO trial
2025· 4 citedOpen Access
A study to learn how well enfortumab vedotin (EV) with pembrolizumab works and how safe it is in people with advanced urothelial cancer: a plain language summary of the EV-302/KEYNOTE-A39 study
Future Oncology·2025Open Access
Identification of a novel papillary renal cell carcinoma molecular subtype characterized by HIF-pathway over-activation
2025
1 Shifts in Water Supply and Demand Shape Land Cover Change
SSRN Electronic Journal·2025Open Access
Basics in Cardiac Intensive Care
2025
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2024· 1 cited
CO25 PRO-WAVE1: Monitoring Patient Reported Outcomes (PROs) in Prostate Cancer Through Wave Health: A Novel ePRO Health Platform
Value in Health·2024Open Access
Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial
ESMO Open·2024· 19 citedOpen Access
P007 PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform
European Urology Open Science·2024Open Access
page 1 of 18Next →

Frequent Co-authors

Daniel Castellano(20), Yohann Loriot(14), Thomas Powles(11), Andrea Necchi(9), Michiel S. van der Heijden(9), Cora N. Sternberg(9), Ugo De Giorgi(7), Gwénaëlle Gravis(7), Se Hoon Park(7), Christopher J. Sweeney(7), Alain Ravaud(6), Begoña Mellado(6), Silke Gillessen(6), Nicholas D. James(6), Margitta Retz(5), Aristotelis Bamias(5), Robert Huddart(5), Scott T. Tagawa(5), Alejo Rodríguez‐Vida(5), Cristina Suárez(5)